Roche Holdings (RHHBF.PK): H1 net profit +39.4% to 5.94B Swiss francs ($6.34B), broadly in line...

|About: Roche Holding Ltd (RHHBF)|By:, SA News Editor
Roche Holdings (RHHBF.PK): H1 net profit +39.4% to 5.94B Swiss francs ($6.34B), broadly in line with forecasts; sales +4% to 23.3B francs. Earnings boosted by its existing portfolio, recently launched cancer medicines Perjeta and Kadcyla, and the continued growth of its clinical laboratory business. Confirms its outlook for the year, and expects FY sales to grow in line with 2012, when revenues increased 7%, while EPS is likely to rise ahead of sales. Roche also expects to further raise its dividend this year. (PR)